FDC Ltd.

View in App
448.20 +4.35 ▲1.0%

24 April 2024, 10:43:57 AM
Volume: 24,824

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fdcindia.com
Market Cap 7,240.98 Cr.
Enterprise Value(EV) 7,218.13 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 17.79 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 25.00 Trailing Twelve Months Ending 2023-12
Industry PE 41.03 Trailing Twelve Months Ending 2023-12
Book Value / Share 126.02 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.53 Calculated using Price: 444.75
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 16.28 Cr. 162,810,084 Shares
FaceValue 1
About FDC Ltd.
FDC Limited is among India's leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world's foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history of 85 years, the Company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio.

FDC Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

FDC Ltd. Performance

View details >>
1 Day
+0.98%
1 Week
-1.23%
1 Month
+4.29%
3 Month
+7.20%
6 Month
+26.41%
1 Year
+54.55%
2 Year
+58.57%
5 Year
+176.07%
10 Year
+225.96%

FDC Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 16.64 16.72 16.03 13.63 12.48 16.03 18.36 11.71 9.84
Return on Capital Employed (%) 23.02 23.11 21.51 19 17.49 21.56 23.74 15.78 13.25
Return on Assets (%) 13.34 13.97 12 9.03 8.2 10.43 11.85 7.59 6.23

FDC Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 936 1,082 1,270 1,276 1,445 1,547 1,734 1,957 1,982 1,973
Non Curr. Liab. 24 20 217 211 229 315 300 391 469 49
Curr. Liab. 188 163 389 480 497 565 622 690 730 321
Minority Int. 0 0 -1 -1
Equity & Liab. 1,148 1,266 1,876 1,968 2,172 2,427 2,655 3,038 3,180 2,342
Non Curr. Assets 646 742 958 977 1,113 1,181 1,303 1,620 1,735 1,366
Curr. Assets 502 523 918 991 1,058 1,245 1,348 1,418 1,443 976
Misc. Exp. not W/O
Total Assets 1,148 1,266 1,876 1,968 2,172 2,427 2,655 3,038 3,180 2,342

FDC Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 889 994 1,014 1,075 1,091 1,344 1,333 1,528 1,784 1,916
Other Income 46 39 50 51 43 69 97 76 51 88
Total Income 935 1,033 1,064 1,126 1,134 1,413 1,430 1,604 1,835 2,004
Total Expenditure -691 -766 -770 -848 -860 -1,051 -999 -1,274 -1,534 -1,585
PBIDT 244 268 294 278 274 362 431 330 301 420
Interest -2 -1 -1 -1 -1 -3 -3 -3 -4 -4
Depreciation -39 -34 -35 -35 -33 -37 -38 -37 -39 -39
Taxation -56 -63 -63 -67 -67 -80 -87 -73 -64 -87
Exceptional Items -6 -1 -2
PAT 148 169 189 174 170 240 301 216 194 289
Minority Interest 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 148 169 189 174 170 240 301 216 194 290
Adjusted EPS 8 9 11 10 10 14 18 13 12 18

FDC Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 150 128 174 154 150 112 250 207 162 155
Cash Fr. Inv. -55 -89 -73 -144 20 -120 -98 -77 -145 11
Cash Fr. Finan. -75 -48 -97 0 -169 0 -142 -129 -10 -180
Net Change 19 -9 4 11 1 -8 10 1 7 -14
Cash & Cash Eqvt 23 15 16 27 28 20 30 30 38 24

FDC Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 69.36 69.50 69.49 69.49 69.50 69.50 69.66 69.66 69.66
Public 30.64 30.51 30.51 30.51 30.50 30.50 30.34 30.34 30.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

FDC Ltd. Announcements

View details >>
Thu, 11 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
FDC Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Wed, 27 Mar 2024
Trading Window-XBRL
FDC LIMITED has informed the Exchange about Closure of Trading Window
Wed, 27 Mar 2024
Trading Window
FDC Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

FDC Ltd. Technical Scans

View details >>
Tue, 23 Apr 2024
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

FDC Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,001.33 1,497.35 +0.9%
Cipla Ltd. 108,812.62 1,380.95 +2.5%
Divi's Laboratories Ltd. 100,075.02 3,804.85 +1.0%
Dr. Reddy's Laboratories Ltd. 99,325.26 5,980.00 +0.5%
Zydus Lifesciences Ltd. 96,553.18 919.20 -4.2%
Mankind Pharma Ltd. 95,896.87 2,412.40 +0.8%
Torrent Pharmaceuticals Ltd. 89,224.37 2,659.95 +0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 39.97 1,497.35 +0.9%
Cipla Ltd. Consolidated 2023-12 29.34 1,380.95 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-12 72.36 3,804.85 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 5,980.00 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.47 919.20 -4.2%
Mankind Pharma Ltd. Consolidated 2023-12 55.52 2,412.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.72 2,659.95 +0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.71 1,497.35 +0.9%
Cipla Ltd. Consolidated 2023-12 4.20 1,380.95 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.68 3,804.85 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,980.00 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 919.20 -4.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.79 2,412.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.48 2,659.95 +0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,497.35 +0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,380.95 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,804.85 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,980.00 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 919.20 -4.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,412.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,659.95 +0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,497.35 +0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,380.95 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,804.85 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,980.00 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 919.20 -4.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,412.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,659.95 +0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,497.35 +0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,380.95 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,804.85 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,980.00 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 919.20 -4.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,412.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,659.95 +0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,497.35 +0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,380.95 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,804.85 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,980.00 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 919.20 -4.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,412.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,659.95 +0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,497.35 +0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,380.95 +2.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,804.85 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,980.00 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 919.20 -4.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,412.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,659.95 +0.9%

FDC Ltd. FAQ's

What is FDC share price?
Can I buy FDC shares now?
What is the Market Cap of FDC?
What are the key metrics to analyse FDC?
What is the 52 Week High and Low of FDC?
What is the trend of FDC share price?